학술논문
Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity.
Document Type
Letter
Author
Source
Angiogenesis; Aug2017, Vol. 20 Issue 3, p287-289, 3p
Subject
Language
ISSN
09696970